News
-
-
PRESS RELEASE
EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital
Heidelberg Pharma AG announces amendment to royalty agreement with HealthCare Royalty and partnership with Soleus Capital, securing upfront and milestone payments -
-
-
-
-
-
PRESS RELEASE
Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma appoints Dr. Dongzhou Jeffery Liu as Chairman and CEO, replacing Prof. Andreas Pahl. The biotech company focuses on ADC technology for cancer treatment -
-
PRESS RELEASE
EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma AG announces changes to the Executive Management Board - Dr. Dongzhou Jeffery Liu appointed as Chairman of the Executive Board and Chief Executive Officer
